Literature DB >> 12235223

Safety issues in using complementary and alternative medicine.

Maurie Markman1.   

Abstract

PURPOSE: A number of reports have documented the apparent increasing popularity of complementary and alternative medicine (CAM) among cancer patients. Unfortunately, there are limited available published data regarding the potential toxicity of a variety of CAM strategies.
METHODS: A review of the medical literature was undertaken to highlight the potential side effects of CAM.
RESULTS: Although many CAM approaches are quite safe, both minor and major toxicities have been documented, including emesis, hypersensitivity reactions, cardiovascular events, neurologic dysfunction, hepatic and renal failure, and the development of malignant disease.
CONCLUSION: It is important that oncologists are aware of what nonprescription CAM medications are being taking by their patients and have a basic understanding of the potential toxicities of these agents.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12235223

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  33 in total

Review 1.  Complementary and alternative medicine (CAM) in Mexican patients with cancer.

Authors:  Raquel Gerson-Cwilich; Alberto Serrano-Olvera; Alberto Villalobos-Prieto
Journal:  Clin Transl Oncol       Date:  2006-03       Impact factor: 3.405

2.  The Quality of Romanian Breast Cancer Websites: a Five-Year Longitudinal Assessment.

Authors:  Valentin Nădăşan; Anca Noela Roşca; Monica Tarcea; Zoltán Ábrám; Marius Măruşteri
Journal:  J Cancer Educ       Date:  2018-06       Impact factor: 2.037

3.  Complementary and alternative medicine use in glioma patients in France.

Authors:  Emilie Le Rhun; Patrick Devos; Véronique Bourg; Amélie Darlix; Véronique Lorgis; Guido Ahle; Mathieu Boone; Luc Taillandier; Elsa Curtit; Louis Gras; Christine Lebrun Frenay; Dorothee Gramatzki; Carole Ramirez; Nicolas Simon; Michael Weller
Journal:  J Neurooncol       Date:  2019-10-21       Impact factor: 4.130

Review 4.  Management of anxiety and sleep disorders: role of complementary and alternative medicine and challenges of integration with conventional orthodox care.

Authors:  Martins Ekor; Oluyomi S Adeyemi; Chiagoziem A Otuechere
Journal:  Chin J Integr Med       Date:  2012-12-29       Impact factor: 1.978

5.  Potential medication problems in older newly diagnosed cancer patients in Canada during cancer treatment: a prospective pilot cohort study.

Authors:  Martine T E Puts; Johanne Monette; Veronique Girre; Beatriz Costa-Lima; Christina Wolfson; Gerald Batist; Howard Bergman
Journal:  Drugs Aging       Date:  2010-07-01       Impact factor: 3.923

6.  The use of dietary supplements in a community hospital comprehensive cancer center: implications for conventional cancer care.

Authors:  Digant Gupta; Christopher G Lis; Timothy C Birdsall; James F Grutsch
Journal:  Support Care Cancer       Date:  2005-04-23       Impact factor: 3.603

7.  Medication problems in older, newly diagnosed cancer patients in Canada: How common are they? A prospective pilot study.

Authors:  Martine T E Puts; Beatriz Costa-Lima; Johanne Monette; Veronique Girre; Christina Wolfson; Gerald Batist; Howard Bergman
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

8.  The behaviors of seeking a second opinion from other health-care professionals and the utilization of complementary and alternative medicine in gynecologic cancer patients.

Authors:  K F Tam; D K L Cheng; T Y Ng; H Y S Ngan
Journal:  Support Care Cancer       Date:  2005-07-20       Impact factor: 3.603

9.  Nurse and patient characteristics predict communication about complementary and alternative medicine.

Authors:  Christine N Spencer; Gabriel Lopez; Lorenzo Cohen; Diana L Urbauer; D Michael Hallman; Michael J Fisch; Patricia A Parker
Journal:  Cancer       Date:  2016-03-17       Impact factor: 6.860

10.  Complementary and alternative medicine use by glioma patients in Switzerland.

Authors:  Günter Eisele; Ulrich Roelcke; Katrin Conen; Fabienne Huber; Tobias Weiss; Silvia Hofer; Oliver Heese; Manfred Westphal; Caroline Hertler; Patrick Roth; Michael Weller
Journal:  Neurooncol Pract       Date:  2018-10-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.